Literature DB >> 8651683

Inactivation of cysteine proteases.

C P Govardhan1, R H Abeles.   

Abstract

The cysteine proteases papain and cathepsin B are inactivated by a Michael acceptor, a peptidyl-beta-chloro-alpha, beta-unsaturated ester (N-Ac-L-Phe-NHCH2-CCl=CH-COOMe). Inactivation occurred concomitant with chloride release which was stoichiometric with the amount of enzyme. This result is consistent with nucleophilic attack of the active site cysteine on the beta-carbon of the inhibitor, followed by expulsion of chloride ion. Inactivation by this class of compounds requires the carbon skeleton about the double bond to be in the trans configuration. The cis isomer was a competitive inhibitor. The difference in the mode of inhibition between the isomers is probably due to non-productive binding of the cis isomer due to bulky chlorine substituent in the beta-position.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8651683     DOI: 10.1006/abbi.1996.0231

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  4 in total

1.  Crystallization and preliminary X-ray diffraction analysis of the protease from Southampton norovirus complexed with a Michael acceptor inhibitor.

Authors:  R J Hussey; L Coates; R S Gill; J N Wright; M Sarwar; S Coker; P T Erskine; J B Cooper; S Wood; I N Clarke; P R Lambden; R Broadbridge; P M Shoolingin-Jordan
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-10-29

2.  Probing the compatibility of type II ketosynthase-carrier protein partners.

Authors:  Andrew S Worthington; Gene H Hur; Jordan L Meier; Qian Cheng; Bradley S Moore; Michael D Burkart
Journal:  Chembiochem       Date:  2008-09-01       Impact factor: 3.164

3.  Identification of a new class of nonpeptidic inhibitors of cruzain.

Authors:  Katrien Brak; Patricia S Doyle; James H McKerrow; Jonathan A Ellman
Journal:  J Am Chem Soc       Date:  2008-04-25       Impact factor: 15.419

4.  A structural study of norovirus 3C protease specificity: binding of a designed active site-directed peptide inhibitor.

Authors:  Robert J Hussey; Leighton Coates; Raj S Gill; Peter T Erskine; Shu-Fen Coker; Ed Mitchell; Jonathan B Cooper; Steve Wood; Robert Broadbridge; Ian N Clarke; Paul R Lambden; Peter M Shoolingin-Jordan
Journal:  Biochemistry       Date:  2010-12-15       Impact factor: 3.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.